Literature DB >> 4577390

Liver disease in kidney transplant patients receiving azathioprine.

P Ireland, A Rashid, F von Lichtenberg, T Cavallo, J P Merrill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4577390

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  8 in total

1.  "Triple infections" (fungal, bacterial and viral) in immunosuppressed renal transplant recipients.

Authors:  J Zazgornik; P Schmidt; H Kopsa; J Thurner; E Deutsch
Journal:  Int Urol Nephrol       Date:  1979       Impact factor: 2.370

2.  Jaundice after renal allotransplantation.

Authors:  M F Mozes; N L Ascher; H H Balfour; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

Review 3.  Problems with immunosuppressive agents in renal disease.

Authors:  J S Cameron
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

4.  Orthotopic liver transplantation in ninety-three patients.

Authors:  T E Starzl; K A Porter; C W Putnam; G P Schroter; C G Halgrimson; R Weil; M Hoelscher; H A Reid
Journal:  Surg Gynecol Obstet       Date:  1976-04

5.  Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease.

Authors:  R M Galbraith; N el Sheikh; B Portmann; A L Eddleston; R Williams; V Parsons; M Bewick; C S Ogg
Journal:  Br Med J       Date:  1976-06-19

6.  Idiopathic portal hypertension in a renal transplant patient after long-term azathioprine therapy.

Authors:  R Lorenz; M Brauer; M Classen; N Tornieporth; K Becker
Journal:  Clin Investig       Date:  1992-02

7.  Pathology of digestive organs in renal transplant recipients.

Authors:  M V Pahl; N D Vaziri; D C Martin
Journal:  J Natl Med Assoc       Date:  1986-08       Impact factor: 1.798

8.  Non-viral related liver enzymes elevation after kidney transplantation.

Authors:  Behzad Einollahi; Alireza Ghadian; Ebrahim Ghamar-Chehreh; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2014-02-05       Impact factor: 0.660

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.